查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1400996

阿片类药物使用障碍 (OUD) 市场，按药物类型、给药途径、配销通路、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Opioid Use Disorder (OUD) Market, by Drug Type, by Route of Administration, by Distribution channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 277 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年阿片类药物使用障碍 (OUD) 市场规模为 28.001 亿美元，2023 年至 2030 年CAGR为 10.59%。

阿片类药物使用疾患 (OUD) 市场-市场动态

阿片类药物成瘾病例增加推动市场需求

目前，全世界人口都受到各种严重和慢性疾病的困扰，包括心血管疾病、癌症和其他疾病。为了治疗这些问题，使用止痛药，特别是鸦片类药物。吸毒常导致病人吸毒成瘾。患者可能由于对这些治疗的依赖增加和突然停药而出现戒断症状。据 CDC 称，预计 2021 年美国 12 岁及以上的人口将有 270 万人患有 OUD。

阿片类药物使用障碍 (OUD) 市场 - 关键见解

根据我们的研究分析师分享的分析，全球阿片类药物使用障碍 (OUD) 市场预计在预测期内（2023-2030 年）每年将以 10.59% 左右的CAGR增长

由于阿片类药物成瘾病例的增加，阿片类药物使用障碍（OUD）行业预计将以显着的速度增长

根据药物类型细分，预计激动剂将在 2022 年显示最大的市场份额

依给药途径细分，2022年静脉注射为主导类型

从配销通路细分来看，2022年医院药局是主导类型

按地区划分，北美是 2022 年的主要收入来源

阿片类药物使用疾患 (OUD) 市场区隔分析：

全球阿片类药物使用障碍 (OUD) 市场根据药物类型、给药途径、配销通路和区域进行细分。

根据药物类型，市场分为三类：激动剂和拮抗剂。由于慢性疼痛发病率的上升、阿片类药物的大量滥用以及易患疼痛疾病的老年人口不断增加，预计激动剂领域将主导市场。

根据配销通路，市场分为两类：医院药房和零售药房。由于患者群体依赖该管道来输送丁丙诺啡等肠外 OUD 药物，医院药房预计将占据全球市场的较大份额。

阿片类药物使用障碍 (OUD) 市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。北美很可能引领市场。这是由于美国有大量的人患有阿片类药物成瘾，该地区存在重要的利益相关者，以及地方政府越来越多地参与对抗这场流行病。根据美国国家生物技术资讯中心 (NCBI) 2020 年发布的一篇文章，美国约有 210 万人患有鸦片类药物使用障碍。

阿片类药物使用疾患 (OUD) 市场-竞争格局：

由于未来几年空调需求的持续发展，全球空气对空气热泵市场由国际和本地生产商组成，使其成为世界上最具竞争力的行业之一。公司透过多种管道销售产品，包括企业网站、电子商务网站、零售商、分销​​商和最终消费者。产品製造商在多个方面竞争，包括产品成本、性能、产品製造、配销通路、声誉和可用性。企业用来扩大影响力和扩大市场份额的一些主要技术包括新产品发布、分销网络开发、研发支出以及併购。例如，2023 年 4 月，纽约州成瘾服务和支持办公室 (OASAS) 和纽约州卫生部 (DOH) 宣布推出丁丙诺啡援助试点计划，该计划将帮助支付阿片类药物的丁丙诺啡费用使用障碍（OUD）治疗。

最近的发展：

2023年3月，Indivior PLC完成对Opiant Pharmaceuticals, Inc.的收购。此次收购将提高 Indivior 在成瘾治疗领域的地位。

目录

第 1 章：阿片类药物使用障碍 (OUD) 市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按药物类型分類的鸦片类药物使用障碍 (OUD) 市场片段
    • 按给药途径分類的鸦片类药物使用障碍 (OUD) 市场片段
    • 按配销通路的鸦片类药物使用障碍 (OUD) 市场片段
    • 阿片类药物使用障碍 (OUD) 市场片段（按国家/地区）
    • 阿片类药物使用疾患 (OUD) 市场片段（按地区）
  • 竞争洞察

第 3 章：阿片类药物使用障碍 (OUD) 主要市场趋势

  • 阿片类药物使用疾患 (OUD) 市场驱动因素
    • 市场驱动因素的影响分析
  • 阿片类药物使用疾患 (OUD) 市场限制
    • 市场限制影响分析
  • 阿片类药物使用疾患 (OUD) 市场机会
  • 阿片类药物使用疾患 (OUD) 市场未来趋势

第 4 章：阿片类药物使用障碍 (OUD) 产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：阿片类药物使用障碍 (OUD) 市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：阿片类药物使用障碍 (OUD) 市场格局

  • 2022 年阿片类药物使用障碍 (OUD) 市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：阿片类药物使用障碍 (OUD) 市场 - 按药物类型

  • 概述
    • 按药物类型分類的细分市场份额分析
    • 激动剂
    • 拮抗剂

第 8 章：阿片类药物使用障碍 (OUD) 市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市占率分析
    • 口服
    • 静脉
    • 舌下含化

第 9 章：阿片类药物使用障碍 (OUD) 市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 医院药房
    • 零售药房

第 10 章：阿片类药物使用障碍 (OUD) 市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美阿片类药物使用障碍 (OUD) 主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按药物类型）
    • 北美市场规模与预测（按管理途径）
    • 北美市场规模和预测（按配销通路）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲阿片类药物使用障碍 (OUD) 主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按药物类型）
    • 欧洲市场规模与预测（按管理途径）
    • 欧洲市场规模和预测（按配销通路）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区阿片类药物使用障碍 (OUD) 主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按药物类型）
    • 亚太地区市场规模与预测（依管理途径）
    • 亚太地区市场规模和预测（按配销通路）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲阿片类药物使用障碍 (OUD) 主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按药物类型）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 拉丁美洲市场规模和预测（按配销通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲阿片类药物使用疾患 (OUD) 主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按药物类型）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模及预测（按配销通路）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 阿片类药物使用障碍 (OUD) 产业

  • 竞争仪表板
  • 公司简介
    • Indivior PLC
    • Alkermes plc
    • Mallinckrodt Pharmaceuticals
    • Reckitt Benckiser Pharmaceuticals (RB)
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV (now part of Viatris Inc.)
    • Otsuka America Pharmaceutical, Inc.
    • Hikma Pharmaceuticals PLC
    • Braeburn Pharmaceuticals
    • Titan Pharmaceuticals, Inc.
    • Camurus AB
    • BioDelivery Sciences International, Inc.
    • Titan Pharmaceuticals, Inc.
    • Esperion Therapeutics, Inc.
    • Kaleo Pharmaceuticals (Known for naloxone products)

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1960

REPORT HIGHLIGHT

Opioid Use Disorder (OUD) Market size was valued at USD 2,800.1 Million in 2022, expanding at a CAGR of 10.59% from 2023 to 2030.

Opioid Use Disorder (OUD) is a chronic health disorder defined by the obsessive and dangerous use of opioids, which can include prescribed medications as well as illegal narcotics such as heroin. It is characterized by a variety of symptoms, including cravings, withdrawal, tolerance, and poor social and vocational performance. Medication-assisted therapy and psychological support are frequently used in effective treatment to help patients recover control of their lives and minimize opiate dependence.

Opioid Use Disorder (OUD) Market- Market Dynamics

Increasing Opioid Addiction Cases to propel market demand

The worldwide population is currently afflicted with a wide spectrum of severe and chronic diseases, including cardiovascular ailments, cancer, and other conditions. To treat these problems, painkillers, particularly opioids, are used. Drug usage frequently leads to drug addiction in patients. Patients may develop drug withdrawal symptoms as a result of their increasing reliance on these treatments and their sudden discontinuation. According to the CDC, a projected 2.7 million persons aged 12 and over in the United States will have OUD in 2021.

Opioid Use Disorder (OUD) Market- Key Insights

As per the analysis shared by our research analyst, the global Opioid Use Disorder (OUD) market is estimated to grow annually at a CAGR of around 10.59% over the forecast period (2023-2030)

The Opioid Use Disorder (OUD) industry is projected to grow at a significant rate due to the increasing opioid addiction cases

Based on drug type segmentation, agonist was predicted to show maximum market share in the year 2022

Based on route of administration segmentation, Intravenous was the leading type in 2022

Based on distribution channel segmentation, hospital pharmacy was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Opioid Use Disorder (OUD) Market- Segmentation Analysis:

The Global Opioid Use Disorder (OUD) Market is segmented on the basis of Drug Type, Route of Administration, Distribution channel, and Region.

The market is divided into three categories based on Drug Type: agonist and antagonist. Due to the rise in the incidence of chronic pain, a significant amount of opioid misuse, and the expanding elderly population susceptible to painful diseases, the agonist segment is predicted to dominate the market.

The market is divided into two categories based on distribution channel: hospital pharmacy and retail pharmacy. The hospital pharmacies segment is expected to account for a larger part of the worldwide market due to the patient population's reliance on this channel for the delivery of parenteral OUD medications such as buprenorphine.

Opioid Use Disorder (OUD) Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is likely to lead the market. This is due to the large number of people in the United States suffering from opioid addiction, the presence of significant stakeholders in the region, and the rising participation of local governments in combating the pandemic. According to a 2020 article released by the National Center for Biotechnology Information (NCBI), around 2.1 million people in the United States suffer with Opioid Use Disorder.

Opioid Use Disorder (OUD) Market- Competitive Landscape:

Due to the continued development in demand for air conditioning in the coming years, the worldwide market for air-to-air heat pumps is made of both international and local producers, making it one of the most competitive sectors in the world. Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, Distribution channel, reputation, and availability. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, April 2023, the New York State Office of Addiction Services and Supports (OASAS) and the New York State Department of Health (DOH) announced the introduction of the Buprenorphine Assistance Pilot Program, which will help with the expense of buprenorphine for opioid use disorder (OUD) treatment.

Recent Developments:

In March 2023, the acquisition of Opiant Pharmaceuticals, Inc. by Indivior PLC was finalized. The purchase will improve Indivior's position in the field of addiction therapy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL OPIOID USE DISORDER (OUD) MARKET KEY PLAYERS

  • Indivior PLC
  • Alkermes plc
  • Mallinckrodt Pharmaceuticals
  • Reckitt Benckiser Pharmaceuticals (RB)
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V. (now part of Viatris Inc.)
  • Otsuka America Pharmaceutical, Inc.
  • Hikma Pharmaceuticals PLC
  • Braeburn Pharmaceuticals
  • Titan Pharmaceuticals, Inc.
  • Camurus AB
  • BioDelivery Sciences International, Inc.
  • Titan Pharmaceuticals, Inc.
  • Esperion Therapeutics, Inc.
  • Kaleo Pharmaceuticals (Known for naloxone products)

GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY DRUG TYPE

  • Agonist
  • Antagonist

GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY ROUTE OF ADMINISTRATION

  • Oral
  • Intravenous
  • Sublingual

GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY DISTRIBUTION CHANNEL

  • Hospital Pharmacy
  • Retail Pharmacy

GLOBAL OPIOID USE DISORDER (OUD) MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Opioid Use Disorder (OUD) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Opioid Use Disorder (OUD) Market Snippet by Drug Type
    • 2.1.2. Opioid Use Disorder (OUD) Market Snippet by Route of Administration
    • 2.1.3. Opioid Use Disorder (OUD) Market Snippet by Distribution Channel
    • 2.1.4. Opioid Use Disorder (OUD) Market Snippet by Country
    • 2.1.5. Opioid Use Disorder (OUD) Market Snippet by Region
  • 2.2. Competitive Insights

3. Opioid Use Disorder (OUD) Key Market Trends

  • 3.1. Opioid Use Disorder (OUD) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Opioid Use Disorder (OUD) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Opioid Use Disorder (OUD) Market Opportunities
  • 3.4. Opioid Use Disorder (OUD) Market Future Trends

4. Opioid Use Disorder (OUD) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Opioid Use Disorder (OUD) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Opioid Use Disorder (OUD) Market Landscape

  • 6.1. Opioid Use Disorder (OUD) Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Opioid Use Disorder (OUD) Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
    • 7.1.2. Agonist
    • 7.1.3. Antagonist

8. Opioid Use Disorder (OUD) Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 8.1.2. Oral
    • 8.1.3. Intravenous
    • 8.1.4. Sublingual

9. Opioid Use Disorder (OUD) Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Hospital Pharmacy
    • 9.1.3. Retail Pharmacy

10. Opioid Use Disorder (OUD) Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Opioid Use Disorder (OUD) Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Opioid Use Disorder (OUD) Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Opioid Use Disorder (OUD) Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Opioid Use Disorder (OUD) Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Opioid Use Disorder (OUD) Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Opioid Use Disorder (OUD) Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Indivior PLC
    • 11.2.2. Alkermes plc
    • 11.2.3. Mallinckrodt Pharmaceuticals
    • 11.2.4. Reckitt Benckiser Pharmaceuticals (RB)
    • 11.2.5. Teva Pharmaceutical Industries Ltd.
    • 11.2.6. Mylan N.V. (now part of Viatris Inc.)
    • 11.2.7. Otsuka America Pharmaceutical, Inc.
    • 11.2.8. Hikma Pharmaceuticals PLC
    • 11.2.9. Braeburn Pharmaceuticals
    • 11.2.10. Titan Pharmaceuticals, Inc.
    • 11.2.11. Camurus AB
    • 11.2.12. BioDelivery Sciences International, Inc.
    • 11.2.13. Titan Pharmaceuticals, Inc.
    • 11.2.14. Esperion Therapeutics, Inc.
    • 11.2.15. Kaleo Pharmaceuticals (Known for naloxone products)

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Opioid Use Disorder (OUD) Market: Drug Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global Opioid Use Disorder (OUD) Market, by Drug Type 2018-2030 (USD Million)
  • TABLE Opioid Use Disorder (OUD) Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Opioid Use Disorder (OUD) Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Opioid Use Disorder (OUD) Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Opioid Use Disorder (OUD) Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Opioid Use Disorder (OUD) Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Opioid Use Disorder (OUD) Market, by Region 2018-2030 (USD Million)
  • TABLE North America Opioid Use Disorder (OUD) Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Opioid Use Disorder (OUD) Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE North America Opioid Use Disorder (OUD) Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Opioid Use Disorder (OUD) Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Opioid Use Disorder (OUD) Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Opioid Use Disorder (OUD) Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Europe Opioid Use Disorder (OUD) Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Opioid Use Disorder (OUD) Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Opioid Use Disorder (OUD) Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Opioid Use Disorder (OUD) Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Opioid Use Disorder (OUD) Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Opioid Use Disorder (OUD) Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Opioid Use Disorder (OUD) Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Opioid Use Disorder (OUD) Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Latin America Opioid Use Disorder (OUD) Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Opioid Use Disorder (OUD) Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Opioid Use Disorder (OUD) Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Opioid Use Disorder (OUD) Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Opioid Use Disorder (OUD) Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Opioid Use Disorder (OUD) Market, by Distribution Channel, 2018-2030 (USD Million)